This is unpublished

Gary H.

he, him, his
Physician & Research Faculty
Professor, Public Health Sciences Division, Fred Hutchinson Cancer Center
Professor, Clinical Research Division, Fred Hutch
Professor, Division of Hematology and Oncology, University of Washington
Adjunct Professor, UW School of Public Health
Adjunct Professor, UW School of Pharmacy

Photo: Fred Hutch

Education, Training, Board Certifications 

  • M.D., State University of New York at Buffalo
  • M.P.H. (Biostatistics), Harvard University
  • Internship and Residency, University of North Carolina, Chapel Hill
  • Fellowship, Roswell Park Memorial Institute
  • Fellowship, Dana Farber Cancer Institute
  • Medical Oncology, American Board of Internal Medicine
  • Internal Medicine, American Board of Internal Medicine
  • Hematology American Board of Internal Medicine

Clinical Expertise   

  • Cancer outcomes
  • Quality of care
  • Health economics
  • Health technology assessment




Research and/or clinical interests 

Dr. Gary Lyman is a medical oncologist, hematologist and public health researcher who focuses on comparative effectiveness, health technology assessment, and health services and outcomes research. Dr. Lyman serves as a senior lead for health care quality and policy within the Hutchinson Institute for Cancer Outcomes Research, or HICOR. An internationally recognized thought leader in cancer care delivery, supportive care and health care policy, his research compares the effectiveness of novel diagnostic and therapeutic strategies; examines clinical decision-making; explores risk modeling and precision medicine; assesses health technology research and synthesis; and delves into the factors that drive disparities in cancer care. He is also interested in cancer prevention, pharmaco-economics, and cancer treatment and supportive care for the elderly. Dr Lyman’s research has been cited more than 68,000 times and is among the top 1% of investigators by citations in Web of Science. In addition to his work at the Fred Hutch, Dr. Lyman holds leadership positions within the American Society of Clinical Oncology as well as the SWOG Cancer Research Network, for which he serves as executive officer for Cancer Care Delivery, Symptom Control and Quality of Life Research, and Immunotherapy Studies.